These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination. Mahan M; Meunier J; Newby M; Young MR J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2. Tanaka M; Ishibashi H; Hirata Y; Miki K; Kudo J; Niho Y J Clin Lab Immunol; 1996; 48(1):17-31. PubMed ID: 10332631 [TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells. Young MR; Young ME; Wepsic HT Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729 [TBL] [Abstract][Full Text] [Related]
6. Rat mammary preadipocytes in culture produce a trophic agent for mammary epithelia-prostaglandin E2. Rudland PS; Twiston Davies AC; Tsao SW J Cell Physiol; 1984 Sep; 120(3):364-76. PubMed ID: 6589225 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo. Young MR; Knies S J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667 [TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. Huang M; Sharma S; Mao JT; Dubinett SM J Immunol; 1996 Dec; 157(12):5512-20. PubMed ID: 8955201 [TBL] [Abstract][Full Text] [Related]
9. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 synthesis by human primary and metastatic bone tumors in culture. Gebhardt MC; Lippiello L; Bringhurst FR; Mankin HJ Clin Orthop Relat Res; 1985 Jun; (196):300-5. PubMed ID: 3858043 [TBL] [Abstract][Full Text] [Related]
11. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. Tilden AB; Balch CM Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Matsumoto-Taniura N; Matsumoto K; Nakamura T Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy. Bahr GM; Rook GA; Stanford JL Clin Exp Immunol; 1981 Sep; 45(3):646-53. PubMed ID: 7039874 [TBL] [Abstract][Full Text] [Related]
14. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck. Kim CD; Sung MW; Lee SJ; Heo DS; Yoon SJ; Kim KH Anticancer Res; 1999; 19(1A):455-9. PubMed ID: 10226582 [TBL] [Abstract][Full Text] [Related]
15. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Huang M; Stolina M; Sharma S; Mao JT; Zhu L; Miller PW; Wollman J; Herschman H; Dubinett SM Cancer Res; 1998 Mar; 58(6):1208-16. PubMed ID: 9515807 [TBL] [Abstract][Full Text] [Related]
16. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response. Lando PA; Edgington TS J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197 [TBL] [Abstract][Full Text] [Related]
17. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins. Berlinger NT Laryngoscope; 1984 Nov; 94(11 Pt 1):1407-10. PubMed ID: 6593559 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor production in stimulated macrophages is down-regulated by concurrently produced prostaglandin E2. Yamada M; Watanabe M; Mue S; Ohuchi K J Pharmacol Exp Ther; 1996 Jun; 277(3):1607-14. PubMed ID: 8667229 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer. Mizutani Y; Okada Y; Terachi T; Yoshida O J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600 [TBL] [Abstract][Full Text] [Related]
20. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Liversidge J; McKay D; Mullen G; Forrester JV Cell Immunol; 1993 Jul; 149(2):315-30. PubMed ID: 8330312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]